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RESEARCH ARTICLE
Black Hispanic and Black Non-Hispanic Breast Cancer Survival
Data Analysis with Half-normal Model Application
Hafiz Mohammad Rafiqullah Khan 1*, Anshul Saxena2, Veronica Vera1, Faheema
Abdool-Ghany1, Kemesha Gabbidon2, Nancy Perea1, Tiffanie Shauna-Jeanne
Stewart3, Venkataraghavan Ramamoorthy3
Abstract
Background: Breast cancer is the second leading cause of cancer death for women in the United States.
Differences in survival of breast cancer have been noted among racial and ethnic groups, but the reasons for
these disparities remain unclear. This study presents the characteristics and the survival curve of two racial and
ethnic groups and evaluates the effects of race on survival times by measuring the lifetime data-based half-normal
model. Materials and Methods: The distributions among racial and ethnic groups are compared using female
breast cancer patients from nine states in the country all taken from the National Cancer Institute’s Surveillance,
Epidemiology, and End Results cancer registry. The main end points observed are: age at diagnosis, survival
time in months, and marital status. The right skewed half-normal statistical probability model is used to show
the differences in the survival times between black Hispanic (BH) and black non-Hispanic (BNH) female breast
cancer patients. The Kaplan-Meier and Cox proportional hazard ratio are used to estimate and compare the
relative risk of death in two minority groups, BH and BNH. Results: A probability random sample method was
used to select representative samples from BNH and BH female breast cancer patients, who were diagnosed during
the years of 1973-2009 in the United States. The sample contained 1,000 BNH and 298 BH female breast cancer
patients. The median age at diagnosis was 57.75 years among BNH and 54.11 years among BH. The results of
the half-normal model showed that the survival times formed positive skewed models with higher variability in
BNH compared with BH. The Kaplan-Meir estimate was used to plot the survival curves for cancer patients; this
test was positively skewed. The Kaplan-Meier and Cox proportional hazard ratio for survival analysis showed
that BNH had a significantly longer survival time as compared to BH which is consistent with the results of the
half-normal model. Conclusions: The findings with the proposed model strategy will assist in the healthcare
field to measure future outcomes for BH and BNH, given their past history and conditions. These findings may
provide an enhanced and improved outlook for the diagnosis and treatment of breast cancer patients in the
United States.
Keywords: Half-normal model - Kaplan-Meier and Cox proportional hazard ratio - survival analysis
Asian Pac J Cancer Prev, 15 (21), 9453-9458

Introduction
Cancer is the most common cause of morbidity and
mortality worldwide (Sankaranarayanan & Ferlay, 2013).
In 2012, approximately, 14 million people were diagnosed
with cancer and over half of those diagnosed succumbed
to the disease (Jemal et al., 2011). Globally, female breast
cancer patients accounted for 1.67 million cases and half
a million deaths (Ferlay et al., 2012; WHO, 2013). In the
United States (U.S.), breast cancer is the most frequently
diagnosed malignancy among all racial and ethnic groups,
and the second leading cause of death due to cancer among
women (Ademuyiwa et al., 2011; DeSantis et al., 2011;

ACS, 2014). Projections for new invasive breast cancer
cases in the U.S. suggest that in the year 2014, around
232,670 women will be diagnosed with breast cancer, and
around 40,000 will die from the disease (NCI, 2014a; NCI,
2014b; Siegel, Ma, Zhou, & Jemal, 2014). In addition, one
out of every eight women will be diagnosed with breast
cancer in her lifetime (DeSantis et al., 2011).
According to the Surveillance, Epidemiology, and
End Results Program (SEER) cancer registry, women
have a 12% chance of being diagnosed with breast cancer
during their lifetime (SEER, 2014a, 2014b). Between the
years, 2002 and 2003 there has been a 7% decrease seen
in breast cancer incidence among women (Jemal et al.,
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2006; ACS, 2013a). This decrease was due to a drop in the
number of users of postmenopausal hormone therapy (HT)
after a study published in 2002 in the Women’s Health
Initiative (Narod, 2011). The study linked the use of HT
to an increased risk of breast cancer and heart disease.
Since then, breast cancer incidence has been relatively
steady (ACS, 2013a; Narod, 2011).
There are several risk factors associated with increased
incidence of breast cancer and this includes genetic
factors, socio-economic status, education level, race and
ethnicity, and access to care (Liu et al., 2012; Cheung,
2013). Age is one of the most predictive factors of breast
cancer; as a woman ages, her risk of being diagnosed with
breast cancer also increases (Virnig et al., 2010; Van de
Water et al., 2012). Around 66% of invasive breast cancers
occur in females over the age of 50, and 12% in women
younger than age 45 (ACS, 2013b). In 2011, the highest
incidence of breast cancer occurred in women between the
ages of 50 and 64 (WHO, 2010). Additionally, delaying
treatment may adversely affect patient prognosis. Women
have reported several reasons for delaying treatment once
a lump has been identified, these reasons included: belief
that symptoms were harmless and temporary, use of
alternative medicines, carelessness, fear of mastectomy,
and fear of social isolation (Memon et al., 2013). However,
the same study showed that women did return for
treatment if the lump size increased, the symptoms became
severe, if they felt concerned and if they were referred
(Memon et al., 2013). Women develop breast cancer when
the abnormal cellular division in the breast grows out of
control. These cancer cells grow to form a large mass or
lump known as a tumor, and these tumors are commonly
classified as ductal carcinoma in situ (DCIS) or lobular
carcinoma in situ (LCIS) depending on the tumor location
and characterization (Virnig et al., 2010). The detection
of cancerous tumors in the breast can be done through a
mammography screening, followed by a confirmatory
biopsy. Women age 20 and older are asked to complete
Breast Self-Examinations (BSE), those in their 20s and
30s are asked to complete a Clinical Breast Exam (CBE)
every three years and to begin mammograms at age 40
(Smith et al., 2011).
Race, ethnicity, and breast cancer
During the years 2006-2010, the average age-adjusted
annual incidence rate of breast cancer for white nonHispanic women living in the United States was 127.3
per 100,000 women per year, followed by 118.4 per
100,000 women per year for black non-Hispanic (BNH)
women and 91.1 per 100,000 women per year for Hispanic
women, of all races (ACS, 2013a). White non-Hispanic
women have the potential for the greatest number of years
lost compared to other ethnic groups (Liu et al., 2012).
They are also more likely to be diagnosed with breast
cancer compared to other ethnic groups (Ooi et al., 2011).
Breast cancer, however, is the second leading cause of
death among black and white Hispanic women resulting in
17,100 new invasive breast cancer cases and 2,400 breast
cancer deaths in 2012 (Siegel, Naishadham, & Jemal,
2011). Using SEER breast cancer data from 2004 to 2009,
Blacks were identified as having the shortest survival
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outcome of most ethnic and racial groups (Cheung, 2013).
In addition, BNH women and Hispanic women, of all
races, are less likely than white non-Hispanic women to be
diagnosed with early stage breast cancer and BNH women
tend to have larger tumors (Ooi et al., 2011; ACS, 2013a).
Low socio-economic status and lack of health
insurance puts BNH women at risk for a higher mortality
rate when diagnosed with breast cancer (Liu et al., 2012).
BNH women have a lower survival rate than other racial
and ethnic groups in the United States and also have a
low chance of recovery due to more aggressive tumors
associated with late stage diagnosis (Siegel at al., 2012b,
2012a; ACS, 2013a). BNH women had a 1.5-2.5 increased
risk of having stage IV breast cancer and are more likely
to die of a cancer specific death compared to white nonHispanic women (Banegas and Li, 2012; Khan et al.,
2014e).
Few research studies exist on cancer related health
disparities among Hispanic women of different races
(Black and White) (Banegas and Li, 2012; Khan et
al., 2014). Hispanic women, of all races, are also more
likely to die from breast cancer in comparison to white
non-Hispanic women, even when diagnosed at the same
stage and age (ACS, 2013a; Siegel at al., 2012b). Hispanic
women, of all races, who do not speak English, have lower
breast cancer screening rates and poorer prognosis once
diagnosed. Hispanic women, of all races, are also more
likely to have advanced stage breast cancer and larger
tumors compared to white non-Hispanic women (NCI,
2014a; NCI, 2014b). In 2010, the CDC showed that breast
cancer was the most commonly diagnosed cancer among
BNH women and was the leading cause of cancer deaths
among this group (Liu et al., 2012). Evidence of racial and
ethnic differences in screening and prognosis continue. For
example, Jewish women are more likely to be screened for
BRAC 1 and 2 compared to BNH and Hispanic women,
of all races (Levy et al., 2011). In addition, BNH women
are typically less trusting of their primary care physicians
and cancer treating teams. English speaking Hispanic
women, of all races, are significantly less trusting of their
diagnosing physician. Low trust among BNH and Hispanic
women, of all races, can signify lower efficacy to complete
course of therapy (Kaiser et al., 2011).
The differences in risk and breast cancer survival
time between two ethnic subgroups can be measured by
comparing the number of days patients were alive after
the diagnosis. A lifetime is measured in different ways
depending on what is being measured, such as death
of a person, administrative censoring, or when a tool
being used breaks, a common observation in biomedical
sciences. Lifetime data has been around since the 1970s,
and while there are many ways to statistically measure
lifetime data by making use of statistical probability
models, such as exponential, gamma, Weibull, and halfnormal model. The half-normal model has recently applied
to solve some challenging problems in the statistical
community, Khan (2012, 2013).
The half-normal model to measure lifetime data has
been studied to a certain extent, but not to compare the
survival model analysis between the ethnicities of BH
and BNH. There are very few authors who have used the
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half-normal model in data analysis, for example, Khan
(2012, 2013), among others.
The half-normal model has a scale parameter, σ. The
probability density function (PDF) of the half normal is
given by
fY(y;σ)=√2÷(σ√π) exp[-y2÷(2σ2)],y>0,

where E[y]=√2÷(σ√π). Figure 4 shows a side-by-side
comparison of breast cancer patient survival days between
female BH and BNH by using the half-normal model.
The maximum likelihood estimation, or MLE, is a
method of estimating the parameter of the half-normal
model. When applied to a data set, the MLE provides
estimate for the model’s parameter. The MLE function
based on a sample of size n data points from the halfnormal model is given by
L=∏ni=1 f(yi,σ)=(1÷σn) exp{-(∑ni=1yi2)÷2σ2}

Given a set of data drawn from a half-normal
probability model, the unknown parameter of σ can be
estimated by the method of maximum likelihood, which
is given by
n
[σ̂=√1÷n (∑y2i)]
i=1

The log-likelihood function of the half-normal model
is given by
logL= -n log σ- (∑y2i÷2σ2).
There have been a few studies conducted to examine
distribution of breast cancer among population belonging
to different Black ethnic subgroups (Banegas and Li,
2012; Ooi et al., 2011). Even fewer researchers used BH
and BNH survival data to model statistical probability
distributions. The goals of this paper are to:
i.Obtain descriptive statistics of both ethnicities (BH
and BNH); ii. Review the right skewed half-normal
model and its estimation of the parameter; and iii. Use
of the Kaplan-Meier survival curve to examine lifetime
distribution of both ethnicities.

Materials and Methods
Breast cancer data was taken from the SEER cancer
registry of the United States. The sample consisted of
608,032 breast cancer cases, which were diagnosed
between years 1973-2009. This data provided us with
information from twelve U.S. cancer registries. Stratified
random sampling was used to select the sub-sample of
BNH and BH breast cancer patients from all female breast
cancer cases. For more about selection of sample from the
SEER cancer registry, readers are referred to Khan et al.
(2014a, 2014b, 2014c, 2014d, 2014e, 2014f).
The frequency distribution table of the selected
sample was used for both ethnicities. Descriptive statistics
including mean, standard deviation (SD), range, and
quartiles for age at diagnosis and survival time were
used. Statistical modeling approach is very important
to compare lifetime data in the field of engineering
and biomedical sciences. To compare the lifetime data
by using statistical probability distribution from both
ethnicities, the half-normal probability model was used
to graphically distinguish both ethnicities. Furthermore,

survival analysis was conducted using Kaplan-Meier (KM) and Cox proportional hazard regression methods to
compare hazard ratios of both ethnicities.
The data analysis for this present study included
frequency table generation, descriptive statistics, and
survival analysis. Calculations were conducted using
SPSS (IBM Corp. (2010)) and SAS® software (SAS
Institute Inc. (2011)). The standard software package
Wolfram Research (2012) “Mathematica version 8.0”
was used to display the graphical representation of the
half-normal probability curve after taking consideration
of the maximum likelihood estimates for the parameter.
The survival times for both ethnicities were plotted
with half-normal probability model and they were
superimposed into a one graph to show their differences.
The Mathematica software also used to draw histograms
for survival times for both ethnicities. The geographic
map of the randomly selected nine states out of the twelve
states was derived using the GMAP procedure in SAS®
software. We used SAS® software to generate the bar
graphs for the breast cancer patients’ survival times and
age at diagnosis both for black Hispanic and black nonHispanic ethnicities. Furthermore, SAS software was used
for plotting K-M graph.

Results
The analytical sample consisted of 1,000 BNH and 298
BH cases. The selected stratified sample consisted of cases
from nine cancer registries. These nine registries included
California (BNH= 17.3%; BH=22.5%), Connecticut
(BNH=9.2%; BH=23.8%), Georgia (BNH=28.2%;
BH=31.5%), Hawaii (BNH=0.5%; BH=0.3%), Iowa
(BNH=0.6%; BH=1%), Michigan (BNH=38.8%;
BH=14.8%), New Mexico (BNH=1.1%; BH=1.7%), Utah
(BNH=0.4%; BH=1.3%), and Washington (BNH=3.9%;
BH=3%).
The mean age of diagnosis for BH cases was
54.17 years and for BNH it was 57.75 years, showing
approximately 3.64-years difference (t=3.8, p<0.001) with
a standard deviation of 14.43 and 14.07, respectively. This
suggests that BH women are diagnosed at a younger age.
The mean survival time (in months) for both ethnicities,
BH and BNH were 70.91 and 92.35 respectively. This
converts to about 5.95 years for BH and 7.70 years for
BNH, suggesting that BNH have a longer survival time
Table 1. Frequency Distribution of Black Hispanic and
Black Non-Hispanic Breast Cancer Patients Selected
from the Nine States
States
California
Connecticut
Georgia
Hawaii
Iowa
Michigan
New Mexico
Utah
Washington
Total

Black non-Hispanic
Count
(%)
173
92
282
5
6
388
11
4
39
1000

17.3
9.2
28.2
0.5
0.6
38.8
1.1
0.4
3.9
100

Black Hispanic
Count
(%)
67
71
94
1
3
44
5
4
9
298
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22.5
23.8
31.5
0.3
1
14.8
1.7
1.3
3
100
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of about 2 years (t=4.7, p<0.001); there was a wider
difference among the standard deviations, where BH
reported 61.40 and BNH reported 89.70. Most cases
were married; 342 (34.2%) of these were BNH, and 124
(41.6%) were BH. The second largest group was ‘single’
for both ethnicities. Widowed was third largest for BNH
and fourth largest for BH.
Figure 1 represents the difference between mean
survival time (months) and mean age at diagnosis (years)
between BNH and BH breast cancer cases. Since there is
no overlap between the two error bars, the difference is
significant at α=0.05. BH cases show significantly lower
age at which they were diagnosed with breast cancer, as
well as a lower mean survival time when compared to
BNH.
The histogram (Figure 2) shows that survival time
of both ethnicities is right skewed. The x-axis represents
survival time in months and y-axis represents frequency.
For BNH, better survival among some cases can be
inferred through the longer survival time at x-axis. For
both ethnicities, most of the survival time frequencies lie
between 0 to 150 data points, which is consistent with the
75% quartile values.
Figure 3 represents the cancer registries that were
selected by stratified random sampling. Most of the
states belonged to either eastern or western part of the
U.S. Despite lower representation in the total sample,
cases from Iowa, New Mexico, and Utah showed higher
survival time. Breast cancer cases from Michigan and
California states showed lower survival as compared to the
rest of the total sample. In graphs stratified by ethnicities,
Washington, New Mexico and Iowa states show higher
survival for BNH cases. In case of BH, Georgia, Michigan

Figure 1. Bar Graph Representing the Mean Age
at Diagnosis (in years) and Mean Survival Time (in
months) for the BNH and BH Cases

and Washington states show higher survival time.
The Maximum Likelihood Estimate (MLE) for the
model’s parameter was σ̂BH=93.728 for the BH sample,
and σ̂BNH=128.711 for the BNH sample, respectively. The
x-axis represents the survival times and y-axis represents
the probability density function (pdf). There are two halfnormal densities plotted in Figure 4. The red solid line
indicates the half-normal density plot based on the BH
survival times and the purple dotted line indicates the
half-normal density plot for the BNH survival times. The
survival times for both ethnicities follow positive skewed
model with their respective variability in survival times. It
is clearly noted that the BNH group has higher variability
compared with BH group as clearly seen from the values
of their corresponding maximum likelihood estimates.

Figure 3. Geographic Plot Showing the States (Shaded)
that were Selected in the Stratified Random Sample

Figure 4. This Figure Shows the Probability Density
Function of the Half Normal Model Measured by
Survival Days of the Cancer Patients. Each line represents
the parameter for each female BH and BNH breast cancer patient.
A. BH, n1=298 and B. BNH n2=1,000
P roduc t-L imit S urv iv al E s timates
1.0

S urvival P robability

0.8

0.6

0.4

0.2

0.0
0

100

200

300

400

S urvival time (months )
E thnic ity

Figure 2. Histogram of Survival Time (Months)
Frequencies for BNH and BH Cases
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B la ck H is pa nic

B la ck non-H is pa nic

Figure 5. Illustration of Kaplan-Meier Survival Curve
Depicting Cumulative Survival Time of Female Breast
Cancer Patients of two Different Ethnicities, BH and
BNH. Curve indicates longer survival time for BNH patients
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The survival curve for BH cases is approximately
overlapping the BNH curve at the beginning (Figure 5).
When both curves reach 100 months, we see a significant
decrease in survival for both BH and BNH cases,
with a significant difference in survival time between
both ethnicities. After around 50 months, BH curve is
significantly below the BNH curve, and this continues
until 300 months.
For binary covariates, hazard ratio is the estimate of
the ratio of the hazard rate in one group to the hazard rate
in another group. The hazard ratio for BNH ethnicity with
BH as reference, was 0.756 (95% CI: 0.663, 0.861), with
χ2=17.89 at p<0.0001. The value of this ratio indicates that
between both ethnicities, the BNH breast cancer patients
have better survival as compared to the BH breast cancer
patients. At the 50 month time-point, BH cases have
around 50% chance of survival as compared to BNH,
who have 58% chance of survival. At 100 months, this
difference is around 10% between both ethnicities, with
BH having around 25% and BNH having around 35%
chances of survival.

Discussion
Past studies have shown that age is the strongest
predictor of breast cancer, but race and ethnicity are
also major risk factors (Akinyemiju et al., 2013; Van de
Water et al., 2012; Virnig, Tuttle, Shamliyan, & Kane,
2010; ACS, 2013b; WHO, 2010). There is significant
evidence showing that notable differences in breast cancer
survival rates between different states, across various
socioeconomic strata, and between different racial and
ethnic groups (Liu et al., 2012). However, few studies
have systematically studied ethnic disparities among
black racial subgroups such as Hispanic and non-Hispanic
(Trapido et al., 1994, 1990). The present study deals
with two different ethnic groups within the black race,
and assesses the outcome of breast cancer. The study
also proposes an alternative methodology to comparing
survival times between these two ethnicities. Statistical
methods were used to describe survival or lifetime data
for the patients and the inferences for observations among
these two ethnicities were calculated. To compare the
survival times for the ethnicities with respect to variability
of the data, the half-normal probability model was used.
The maximum likelihood method was used to measure
the variability from both ethnicities data.
In K-M survival estimates, BNH had 66 (95% CI: 5871) months of median survival time as compared to 49.5
(95% CI: 45-60) months for BH. In Figure 5, we observe
that BNH and BH survival curves are splitting at around
50 month time-point. This significant gap in between two
survival curves was consistent until the end. Hazard ratio
suggests that BNH breast cancer cases have around 24%
better chance of survival as compared to BH breast cancer
cases. Using the survival data the resulting survival curve
plotted through K-M estimate were similar to the halfnormal model, a rightly skewed distribution. The x-axis,
denoted by survival time, on both Figures 4 and 5 showed
similar range and significant differences.
In the selected sample, most of the BNH cases came

from the Michigan registry (38.8%), and most of the BH
cases from Georgia registry (31.5%). Both states are
part of the eastern region of the United States, but the
geographical location differs. In our sample, the two least
represented registries were Utah with 0.4% BNH cases
and Hawaii with 0.3% BH cases. The results suggest
that BH cases are diagnosed at least 3 years earlier as
compared to the BNH cases. Some previous studies
have also reported that BH are generally diagnosed at an
earlier age as compared to other ethnicities and the risks
of stage II and stage III breast cancer had no significant
differences across non-Hispanic black, Hispanic white
and Hispanic black women (Banegas and Li, 2012; Ooi
et al., 2011). In this study, the PDF from half normal
distribution suggests that BH women were at a higher risk
of dying from breast cancer. Although, age at diagnosis
was statistically lower in BH cases, it did not contribute
in the longer survival. Two possible explanations could be
that BH women develop more aggressive forms of breast
cancer as compared to BNH and breast cancer disparities
among this subgroup is significantly higher as compared
to BNH population.
Our study has some limitations. The data was obtained
from the SEER database, and there is a possibility
that some cases were misclassified in term of race and
ethnicity. The sample size differed for each ethnicity;
BNH had a sample size of 1000, whereas BH only had 300
(two cases with missing information were excluded). The
cancer registries selected by stratified random sampling
covered cases from eastern and western coast of the U.S.
and cases from the central part were under represented.
The PDF of the half normal distribution was positively
skewed and suggested better survival for BNH cases,
however, different sampling techniques may produce
different sigma (σ) values depending on the selection of
sample data points, resulting in a different graph. It should
be noted how the Kaplan-Meier estimate curve was right
skewed and similar to the positively skewed curve of the
half-normal model. The Kaplan-Meier estimate showed
that BNH had a longer survival time than BH. Although
the difference in mean survival time was statistically
significant, stratified random sampling with larger samples
may change the direction of result.
Our analysis showed that disparities in survival times
differ between and within ethnic groups. Increased efforts
should be used to address the care and diagnosing needs
of black Hispanics in order to increase survival times.
Black non-Hispanics having a later diagnosis time may
also need to be addressed in order to ensure diagnosis is
occurring in earlier stages of the disease.
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